Want to see how your resume matches up to this job?
A free trial of our JobsAI will help! With over 2,000 biopharma executives loving it, we think you will too!
Try it now โ JobsAI.
Role Summary
Responsibilities
Develop and optimize physiologically relevant in vitro models, including providing technical expertise, design and execute qualification plans, and establish relevant endpoint assays to dissect the molecular mechanisms of toxicity.
Independently review literature to generate hypotheses for experimental testing. Design and execute relevant experiments to test hypotheses, including data analysis and its interpretation.
Collaborate with external vendors on technology and assay evaluation, where appropriate.
Work with project teams to address and investigate safety mechanisms and help projects meet development timelines.
Author investigative reports to support inclusion of results in regulatory submissions as needed.
Represent Sanofi on external consortia.
Qualifications
PhD in a biological field with 0-3 years of postdoctoral experience OR Masterโรรดs Degree with 4+ years relevant experience in an academic or biopharmaceutical setting.
A degree in toxicology, pharmacology, immunology, biomedical engineering, or equivalent is preferred.
Proven experience and expertise in mammalian cell culture (primary, iPSC), imaging (high content, confocal), molecular biology (RNA, DNA, protein) endpoints, and biochemical endpoints is a must.
Working knowledge of organ-on-a-chip/MPS, 3D models, or complex in vitro systems will be an advantage.
Experience in toxicity assays related to liver, kidney or immunology is also a plus.
Established record of scientific contribution in peer-reviewed journals and scientific symposiums.
Excellent verbal and written communication skills.
Skills
In vitro model development and validation
Literature review and hypothesis generation
Collaborative work with internal and external partners
Education
PhD in biological field or Masterโรรดs with relevant experience as specified above.
Additional Requirements
Occasional domestic travel to scientific conferences as permitted by travel policies. Availability to start in Q1 2026.
The position is lab-based and requires on-site work in Cambridge, MA.